Article - 01/12/2015 Process optimisation in the operating theatre Modern IT solutions and the digital networking of devices and work processes permeate many areas of life, and this does not stop at hospital gates. A cooperative project, InnOPlan, coordinated by KARL STORZ GmbH & Co. KG in Tuttlingen, is studying data-driven optimisation of processes in operating theatres. https://www.gesundheitsindustrie-bw.de/en/article/news/process-optimisation-in-the-operating-theatre
Retrospective Meet & Match Pharmaceutical Process Technology - 07/04/2016 Speed dating for Pharmaceutical Process Technology – a business flirt at Bosch The speed dating format is no longer just a popular and simple dating method for lonely hearts, but has also become a rewarding way for establishing new business contacts and connections quickly and efficiently. BIOPRO Baden-Württemberg chose speed networking, as speed dating is called in the corporate world, for its recent Meet & Match event on pharmaceutical process technology, which took place on 15th March 2016 with the support of Bosch…https://www.gesundheitsindustrie-bw.de/en/article/press-release/speed-dating-for-pharmaceutical-process-technology-a-business-flirt-at-bosch
Article - 01/03/2017 foxySpec – an analysis system with huge potential for bioproduction and diagnostics The mass spectrometry-based foxySpec system enables the monitoring of gases and liquids simultaneously in real time. These simultaneous measurements make the system interesting for medical diagnostics applications. However, bioproduction can also benefit from foxySpec, which can also be used to measure a large number of products during the production process in real time, thus supporting smooth processes in fermenters. https://www.gesundheitsindustrie-bw.de/en/article/news/foxyspec-an-analysis-system-with-huge-potential-for-bioproduction-and-diagnostics
Article - 07/06/2017 Industry 4.0: Pfizer opens continuous manufacturing plant in Freiburg On 23rd May 2017, Pfizer officially opened a modern continuous manufacturing plant in Freiburg, thus setting a new technological standard for tablet production. A groundbreaking ceremony to inaugurate Pfizer’s new PCMM plant was held at the same time. Pfizer is investing around 50 million euros in the Freiburg facility. https://www.gesundheitsindustrie-bw.de/en/article/news/industry-40-pfizer-opens-continuous-manufacturing-plant-in-freiburg
Article - 02/06/2017 SÜDPACK: a great example of biotech as a cross-sectoral technology SÜDPACK Verpackungen is a qualified supplier of plastic films to the biopharmaceutical industry. The company is the leading European manufacturer of packaging products for the food industry and also offers its expertise to the biopharmaceutical industry. In 2011, SÜDPACK created an exclusive cooperation partnership with Sartorius Stedim Biotech, a global technology provider for the pharmaceutical biotech industry, which has now been extended…https://www.gesundheitsindustrie-bw.de/en/article/news/suedpack-a-great-example-of-biotech-as-a-cross-sectoral-technology
Press release - 13/11/2009 Second-generation biofuels The Distillery for Research and Training at the University of Hohenheim has been reopened after the completion of renovation work costing around 1.2 million euros. The distillery is now equipped with a computer-operated process-control system and modern sensors, all state-of-the-art technology for the fermentation processes at Hohenheim. The new distillery pilot plant has a fermentation room for work with genetically modified organisms.…https://www.gesundheitsindustrie-bw.de/en/article/press-release/second-generation-biofuels
High-tech - 20/10/2016 Industry 4.0 in the medical technology and pharmaceutical industry sectors The digitalisation of industry affects the entire value chain. From individual products to digitising workflows in companies and connecting companies with clients and service providers via the Internet of Things – Industry 4.0 makes completely new manufacturing processes possible and requires new and specific business models. https://www.gesundheitsindustrie-bw.de/en/article/dossier/industry-40-in-the-medical-technology-and-pharmaceutical-industry-sectors
Press release - 04/02/2010 QIAGEN acquires ESE GmbH QIAGEN N.V. has announced its acquisition of ESE GmbH a privately owned developer and manufacturer of UV and fluorescence optical measurement devices. ESE GmbH is based in Stockach Germany. The cash transaction is valued at up to US19 million.https://www.gesundheitsindustrie-bw.de/en/article/press-release/qiagen-acquires-ese-gmbh
Pharmaceutical research and life sciences profit from unique biosensor technology - 18/09/2015 Biametrics GmbH concludes financing round with 3.1 Million Euro Biametrics GmbH today announced the completion of their most recent financing round with €3.1 Million. Partners of the A Series Investment were LBBW Venture GmbH, MBG Mittelständische Beteiligungsgesellschaft BW, and KfW Bankengruppe. Together with seed investors HTGF and Seedfonds BW, they are aiming to accelerate the expansion of Biametrics’ bioanalytical business activities to an international level. The fresh capital will facilitate the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/biametrics-gmbh-concludes-financing-round-with-31-million-euro
Press release - 21/01/2008 Micro-biolytics GmbH - Top spectroscopy technology for the pharmaceutical industry Micro-biolytics GmbH now based in the Esslingen-based Life Science Centre develops and produces microsystems solutions for bioanalytical issues. With the support of networks micro-biolytics is hoping to considerably expand its activities.https://www.gesundheitsindustrie-bw.de/en/article/press-release/micro-biolytics-gmbh-top-spectroscopy-technology-for-the-pharmaceutical-industry
Article - 24/09/2009 Bacteria to produce bioplastics Polyhydroxyalkanoates are storage substances produced and stored by many cells plants and bacteria only in times when they lack lack important nutrients. A particular property of these plastics-related biopolymers is that their composition and hence their material properties can be regulated by the fermentation process.https://www.gesundheitsindustrie-bw.de/en/article/news/bacteria-to-produce-bioplastics
Article - 11/02/2013 Quality management: burden or opportunity? Companies are facing increasing demands. Globalisation and an increasingly quality-conscious market increase competition and pricing pressure. To remain globally competitive companies need a product and service quality that will satisfy the customer in the long term. Alexander Cansier managing director of OrgaConnect GmbH has specialised in the support of small and medium-sized companies in the life sciences pharmaceutical and medical technology…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-management-burden-or-opportunity
Article - 05/03/2009 Christian Wirtz prefers a navigation system when operating on the brain One job but two workplaces Christian Rainer Wirtz has for some time now been commuting regularly along the Danube river between the Bavarian city of Günzburg and the Baden-Württemberg city of Ulm. The new medical director and professor for neurosurgery at the Ulm University Hospital runs a hospital on two sites i.e. the Günzburg District Hospital and the Safranberg Hospital in Ulm.https://www.gesundheitsindustrie-bw.de/en/article/news/christian-wirtz-prefers-a-navigation-system-when-operating-on-the-brain
Article - 01/09/2011 Quality by Design – a paradigm change in bioprocess development Bioprocess technology has undergone a fundamental change with regard to the criteria used for validating product quality: around ten years ago, the U.S. Food and Drug Administration (FDA) revised the 1987 process validation guidance and the subsequent establishment of the Process Analytical Technology (PAT) initiative heralded a paradigm change in bioprocess understanding and control. The FDA’s guidance underwent a paradigm shift from what was…https://www.gesundheitsindustrie-bw.de/en/article/news/quality-by-design-a-paradigm-change-in-bioprocess-development
Article - 06/02/2012 Ten outstanding ideas in biotechnology and medical technology The results of the feasibility studies funded under the Idea Competition in Biotechnology and Medical Technology were presented in the Haus der Wirtschaft in Stuttgart between 16th and 18th January 2012. Ten of the 42 project ideas were recommended for further funding.https://www.gesundheitsindustrie-bw.de/en/article/news/ten-outstanding-ideas-in-biotechnology-and-medical-technology